Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

SpyGlass Pharma, Inc. (SGP)

$20.49 -1.87% NASDAQ: SGP · 15-min delayed
  • ALISO VIEJO, California
  • Public · NASDAQ: SGP
  • 65 employees
$627.9MMarket cap
-$39.9MNet income
65Employees
SGPNASDAQ
2026IPO

About SpyGlass Pharma, Inc.

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Net income
-$39.9M
Total assets
$115.9M
Market cap
$627.9M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: SGP
$20.49 -1.87%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$17.56 $29.68

52-week range

Market cap
$627.9M
Dividend yield
1.27%
Shares outstanding
30.6M
Open
Day range
Prev close
Volume
IPO date
Feb 6, 2026

SpyGlass Pharma, Inc. (SGP) Stock Price

  • Reported a net loss of $39.9M.
  • Trading 31% below its 52-week high.
  • Pays a dividend yielding about 1.27% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review SpyGlass Pharma, Inc..

Write a review
Newsroom

News about SpyGlass Pharma, Inc.

News & sentiment via Polygon.io

FAQ

SpyGlass Pharma, Inc.: frequently asked questions

Is SpyGlass Pharma, Inc. an American company?

SpyGlass Pharma, Inc. is a US-based company headquartered in Aliso Viejo, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is SpyGlass Pharma, Inc. headquartered?

SpyGlass Pharma, Inc. is headquartered in Aliso Viejo, California, United States.

Is SpyGlass Pharma, Inc. publicly traded?

Yes — SpyGlass Pharma, Inc. is a publicly traded company. Its stock trades under the ticker symbol SGP on the NASDAQ.

What does SpyGlass Pharma, Inc. do?

SpyGlass Pharma, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →